Michael Deperro - Rezolute Senior Development
| RZLT Stock | USD 2.66 0.06 2.31% |
Executive
Michael Deperro is Senior Development of Rezolute
| Address | 201 Redwood Shores Parkway, Redwood City, CA, United States, 94065 |
| Phone | 650 206 4507 |
| Web | https://www.rezolutebio.com |
Rezolute Management Efficiency
The company has return on total asset (ROA) of (0.3095) % which means that it has lost $0.3095 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4879) %, meaning that it created substantial loss on money invested by shareholders. Rezolute's management efficiency ratios could be used to measure how well Rezolute manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.4 in 2024. Return On Capital Employed is likely to gain to -0.52 in 2024. At this time, Rezolute's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 2.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 3.6 M in 2024.Similar Executives
| Found 12 records | EXECUTIVE Age | ||
| FACS FACS | Eledon Pharmaceuticals | N/A | |
| Mary Mcneil | Clene Inc | N/A | |
| Jennifer Johansson | Larimar Therapeutics | N/A | |
| Mark ESQ | Clene Inc | 66 | |
| Jerry JD | Clene Inc | N/A | |
| John Berman | Larimar Therapeutics | N/A | |
| MHS MD | Clene Inc | N/A | |
| Bryan JD | Eledon Pharmaceuticals | 44 | |
| Gopi MBA | Larimar Therapeutics | 53 | |
| DO Sr | Larimar Therapeutics | 63 | |
| John Herberger | Eledon Pharmaceuticals | N/A | |
| Lynn Purkins | Reneo Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.31 |
Rezolute Leadership Team
Elected by the shareholders, the Rezolute's board of directors comprises two types of representatives: Rezolute inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rezolute. The board's role is to monitor Rezolute's management team and ensure that shareholders' interests are well served. Rezolute's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rezolute's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Morgan Fields, Chief Accounting Officer | ||
| Hoyoung Huh, Independent Director | ||
| Nevan Elam, Chairman of the Board and Presidentident, CEO | ||
| Sankaram Mantripragada, Chief Scientific Officer | ||
| Raj MD, VP Development | ||
| David Welch, Director | ||
| Keith Vendola, CFO | ||
| Gilbert Labrucherie, Director | ||
| Michael Deperro, Senior Development | ||
| LLM JD, Chief Officer | ||
| Gopal MBBS, Senior Development | ||
| MD MBA, Director Affairs | ||
| Daron Evans, Chief Officer | ||
| YoungJin Kim, Director | ||
| Erin OBoyle, Senior Operations | ||
| Chris Milks, VP Finance | ||
| MS MBA, Chief Officer | ||
| Tae Kim, Independent Director | ||
| Nevan JD, CEO Founder | ||
| Young Sung, Director | ||
| Robyn Sweinhart, VP Quality | ||
| Brian MD, Chief Officer | ||
| Michael Covarrubias, Senior Management | ||
| Samir Patel, Independent Director |
Rezolute Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rezolute a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.31 | ||||
| Current Valuation | 15.32 M | ||||
| Shares Outstanding | 40.13 M | ||||
| Shares Owned By Insiders | 20.38 % | ||||
| Shares Owned By Institutions | 76.07 % | ||||
| Number Of Shares Shorted | 242.67 K | ||||
| Price To Book | 1.17 X | ||||
| EBITDA | (51.75 M) | ||||
| Net Income | (51.79 M) |
Currently Active Assets on Macroaxis
When determining whether Rezolute is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Rezolute Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Rezolute Stock. Highlighted below are key reports to facilitate an investment decision about Rezolute Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rezolute. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Rezolute Stock please use our How to Invest in Rezolute guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Rezolute Stock analysis
When running Rezolute's price analysis, check to measure Rezolute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rezolute is operating at the current time. Most of Rezolute's value examination focuses on studying past and present price action to predict the probability of Rezolute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rezolute's price. Additionally, you may evaluate how the addition of Rezolute to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Rezolute's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rezolute. If investors know Rezolute will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rezolute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Return On Assets (0.31) | Return On Equity (0.49) |
The market value of Rezolute is measured differently than its book value, which is the value of Rezolute that is recorded on the company's balance sheet. Investors also form their own opinion of Rezolute's value that differs from its market value or its book value, called intrinsic value, which is Rezolute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rezolute's market value can be influenced by many factors that don't directly affect Rezolute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rezolute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rezolute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rezolute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.